Insider Trading History of Sassine Andy

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Sassine Andy since 2017. This trader's CIK number is 1515322. At the time of last reporting, Sassine Andy was the Chief Financial Officer of Arcturus Therapeutics Holdings Inc.. (stock ticker symbol ARCT). Also see all insider trading activities at Arcturus Therapeutics Holdings Inc..

Note that in the past SASSINE ANDY also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Metavia Inc. (GEMP) by Sassine Andy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 GEMP 21,119 $199,996 0 $0 0 $0

Yearly summary of insider trading at Icad Inc (ICAD) by Sassine Andy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ICAD 0 $0 40,000 $230,200 0 $0
2021 ICAD 0 $0 80,000 $779,300 0 $0
2020 ICAD 0 $0 60,000 $584,680 0 $0

Yearly summary of insider trading at Arcturus Therapeutics Holdings Inc. (ARCT) by Sassine Andy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 ARCT 1,238 $20,498 0 $0 0 $0
2024 ARCT 0 $0 50,000 $1,601,500 0 $0
2020 ARCT 5,000 $148,700 0 $0 0 $0
2019 ARCT 25,649 $263,964 0 $0 0 $0


Insider trading activities at 3 companies by Sassine Andy:

1. Metavia Inc. (GEMP)

2. Icad Inc (ICAD)

3. Arcturus Therapeutics Holdings Inc. (ARCT)

Table 1. Insider trading of Metavia Inc. (GEMP) by Sassine Andy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-03-10 GEMP Buy 21,119 9.47 199,996

Table 2. Insider trading of Icad Inc (ICAD) by Sassine Andy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-07 ICAD Sale 10,000 5.26 52,600
2022-02-08 ICAD Sale 10,000 5.49 54,900
2022-01-06 ICAD Sale 10,000 6.20 62,000
2022-01-07 ICAD Sale 10,000 6.07 60,700
2021-12-07 ICAD Sale 10,000 7.28 72,800
2021-12-06 ICAD Sale 10,000 6.71 67,100
2021-11-08 ICAD Sale 10,000 10.89 108,900
2021-11-09 ICAD Sale 10,000 10.30 103,000
2021-10-06 ICAD Sale 10,000 10.56 105,600
2021-10-07 ICAD Sale 10,000 10.42 104,200
2021-09-13 ICAD Sale 10,000 11.09 110,900
2021-09-14 ICAD Sale 10,000 10.68 106,800
2020-09-08 ICAD Sale 10,000 9.40 93,980
2020-09-09 ICAD Sale 10,000 9.47 94,750
2020-08-06 ICAD Sale 10,000 10.31 103,080
2020-08-07 ICAD Sale 10,000 10.28 102,820
2020-07-14 ICAD Sale 10,000 9.47 94,750
2020-07-13 ICAD Sale 10,000 9.53 95,300

Table 3. Insider trading of Arcturus Therapeutics Holdings Inc. (ARCT) by Sassine Andy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-15 ARCT Buy 1,238 16.56 20,498
2024-06-12 ARCT Sale 50,000 32.03 1,601,500
2020-06-10 ARCT Buy 5,000 29.74 148,700
2019-12-05 ARCT Buy 5,649 9.73 54,964
2019-12-03 ARCT Buy 10,000 10.00 100,000
2019-08-23 ARCT Buy 10,000 10.90 109,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sassine Andy (Chief Financial Officer of Arcturus Therapeutics Holdings Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.